• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
april@madhedgefundtrader.com

About april@madhedgefundtrader.com

This author has not written his bio yet.
But we are proud to say that april@madhedgefundtrader.com contributed 2288 entries already.

Entries by april@madhedgefundtrader.com

Jacque's Post

March 22, 2024

  (SUMMARY OF JOHN’S MARCH 20, 2024, WEBINAR) March 22, 2024   Title:  Commodities are Back Trade Alert Performance March:  1.34% Since Inception:  681.11% Average annualized return:  +51.40 for 16 years Trailing One Year Return:  +48.70%   Portfolio: (TLT) 4/$87 - $90 call spread (FCX) 4/$37 - $40 call spread (XOM) 4/ $100 - $105

Diary, Newsletter, Summary

March 22, 2024

Global Market Comments March 22, 2024 Fiat Lux    Featured Trade: (MARCH 20 BIWEEKLY STRATEGY WEBINAR Q&A), (DIS), (GLD), (BITB), (UUP), (FXY), (F), (TSLA), (NVDA), (FCX), (UNG), (TLT), (MCD)

Diary, Newsletter

March 20 Biweekly Strategy Webinar Q&A

Below please find subscribers’ Q&A for the March 20 Mad Hedge Fund Trader Global Strategy Webinar, broadcast from Silicon Valley. Q: Do you recommend a form of dollar-cost averaging, and what is it? A: Absolutely, yes. It is impossible for anybody to get an absolute bottom when you're buying, so the best thing to do

Diary, Newsletter, Quote of the Day

March 22, 2024 - Quote of the Day

“If we’re in a bubble, then we’ll act bubbly,” said legendary hedge fund manager, David Tepper.  

Tech Alert

Trade Alert - (ADBE) March 21, 2024 - BUY

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.

Biotech Letter

March 21, 2024

Mad Hedge Biotech and Healthcare Letter March 21, 2024 Fiat Lux Featured Trade: (THE COMEBACK STORY WE'RE ALL HERE FOR) (PFE), (GSK), (LON)

Biotech Letter

The Comeback Story We're All Here For

Well, well, well. Pfizer (PFE) has been on a bit of a wild ride lately, hasn't it? Its shares have taken a nosedive, dropping over 50% since the company’s glory days in late 2021. But before you start yelling "timber!" and running for cover, hear me out. I have a hunch that Pfizer's still got

Diary, Newsletter, Summary

March 21, 2024

Global Market Comments March 21, 2024 Fiat Lux  Featured Trade: (REVISITING THE FIRST SILVER BUBBLE), (SLV), (SLW)

Tech Letter

March 20, 2024

Mad Hedge Technology Letter March 20, 2024 Fiat Lux   Featured Trade: (A NEW SET OF CHIPS ARE COMING) (NVDA)

Tech Letter

A New Set Of Chips Are Coming

The accolades keep raining down on Nvidia (NVDA) CEO Jensen Huang. I even heard one person say he is the new Steve Jobs. Those are quite lofty compliments for a guy who has been under the radar for quite a long time. However, he can’t hide anymore as NVDA’s share price has skyrocketed and the

Page 160 of 227«‹158159160161162›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
  • Privacy Policy
  • Disclaimer
  • FAQ
Scroll to top